In this episode, Beatriz Grinsztejn, MD, PhD, discusses the data and recommendations for addressing social determinants as a strategy to support PrEP persistence and engagement for transgender women, including: HIV prevalence among transgender womenData on the PrEP cascade from the PrEParadas study of daily FTC/TDF among transgender womenData from the ImPrEP Study on early loss to follow-up, adherence, long-term engagement, and HIV incidence among transgender womenBarriers to PrEP uptake and adherence for transgender womenDrug–drug interactions between PrEP and feminizing hormone therapyIncreasing PrEP uptake and retention with peer health navigation for transgender womenFacultyBeatriz Grinsztejn, MD, PhDDirectorHIV/STI Clinical Research LaboratoryInstituto Nacional de Infectologia Evandro Chagas-FiocruzRio de Janeiro, BrazilIAS President-ElectLink to full program: https://clinicaloptions.com/CE-CME-program/infectious-disease/staying-on-track-strategies-to-support-prep-persistence-and-reengagement/17634